CTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial; - Company Expects to Report Topline Data by the End of 2020 -

Press/Media

Period1 Jun 2020

Media coverage

1

Media coverage

  • TitleCTI BioPharma Announces Enrollment of First Patient in COVID-19 PRE-VENT Phase 3 Clinical Trial; - Company Expects to Report Topline Data by the End of 2020 -
    Media name/outletPR Newswire
    Country/TerritoryUnited States
    Date1/06/20
    PersonsJohn Mascarenhas